Plastic surgical delivery systems for targeted gene therapy

被引:24
作者
Ghali, Shadi [1 ]
Dempsey, Marlese P. [1 ]
Jones, Deirdre M. [1 ]
Grogan, Raymond H. [1 ]
Butler, Peter E. [2 ]
Gurtner, Geoffrey C. [1 ]
机构
[1] Stanford Univ, Sch Med, Dept Surg, Div Plast Surg, Stanford, CA USA
[2] Royal Free Hosp, Dept Plast & Reconstruct Surg, London NW3 2QG, England
关键词
targeted gene therapy; delivery systems; microvascular free flaps;
D O I
10.1097/SAP.0b013e31806917b0
中图分类号
R61 [外科手术学];
学科分类号
摘要
The expansion of gene therapy applications from inherited disorders to acquired conditions has been mirrored by an exponential rise in both experimental work and clinical trials. This review highlights current plastic surgical delivery systems and clinical applications for targeted gene therapy. We revisit some of the vectors used both experimentally and in clinical gene therapy trials, with an emphasis on developments in plastic surgical delivery systems resulting in improved targeting of therapeutic genes. In addition, we discuss a novel technique, for the delivery of gene therapy Using the ex vivo transduction of free flaps, developed in our laboratory. This delivery system achieves targeted high-level transgene expression with minimal demonstrable systemic toxicity. Advances in delivery systems are essential for translating basic research into clinical therapeutics.
引用
收藏
页码:323 / 332
页数:10
相关论文
共 104 条
  • [1] Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning
    Aiuti, A
    Slavin, S
    Aker, M
    Ficara, F
    Deola, S
    Mortellaro, A
    Morecki, S
    Andolfi, G
    Tabucchi, A
    Carlucci, F
    Marinello, E
    Cattaneo, F
    Vai, S
    Servida, P
    Miniero, R
    Roncarolo, MG
    Bordignon, C
    [J]. SCIENCE, 2002, 296 (5577) : 2410 - 2413
  • [2] Ultrasound enhancement of cationic lipid-mediated gene transfer to primary tumors following systemic administration
    Anwer, K
    Kao, G
    Proctor, B
    Anscombe, I
    Florack, V
    Earls, R
    Wilson, E
    McCreery, T
    Unger, E
    Rolland, A
    Sullivan, SM
    [J]. GENE THERAPY, 2000, 7 (21) : 1833 - 1839
  • [3] Gene therapy and heart transplantation
    Ardehali, A
    Reddy, R
    Laks, H
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2000, 9 (05) : 1021 - 1027
  • [4] Endothelial progenitor cells for postnatal vasculogenesis
    Asahara, T
    Kawamoto, A
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2004, 287 (03): : C572 - C579
  • [5] Stem cell therapy and gene transfer for regeneration
    Asahara, T
    Kalka, C
    Isner, JM
    [J]. GENE THERAPY, 2000, 7 (06) : 451 - 457
  • [6] Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization
    Asahara, T
    Masuda, H
    Takahashi, T
    Kalka, C
    Pastore, C
    Silver, M
    Kearne, M
    Magner, M
    Isner, JM
    [J]. CIRCULATION RESEARCH, 1999, 85 (03) : 221 - 228
  • [7] Transfection of NFκB-decoy oligodeoxynucleotides using efficient ultrasound-mediated gene transfer into donor kidneys prolonged survival of rat renal allografts
    Azuma, H
    Tomita, N
    Kaneda, Y
    Koike, H
    Ogihara, T
    Katsuoka, Y
    Morishita, R
    [J]. GENE THERAPY, 2003, 10 (05) : 415 - 425
  • [8] Gene therapy of human disease
    Balicki, D
    Beutler, E
    [J]. MEDICINE, 2002, 81 (01) : 69 - 86
  • [9] Adenovirus vectors for gene delivery
    Benihoud, K
    Yeh, P
    Perricaudet, M
    [J]. CURRENT OPINION IN BIOTECHNOLOGY, 1999, 10 (05) : 440 - 447
  • [10] Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5
    Bergelson, JM
    Cunningham, JA
    Droguett, G
    KurtJones, EA
    Krithivas, A
    Hong, JS
    Horwitz, MS
    Crowell, RL
    Finberg, RW
    [J]. SCIENCE, 1997, 275 (5304) : 1320 - 1323